Skip to main content
Top
Published in: Journal of Bone and Mineral Metabolism 3/2021

01-05-2021 | Diabetes | Original Article

Evaluation of aortic calcification using a three-dimensional volume-rendering method in patients with end-stage kidney disease

Authors: Hideki Fujii, Keiji Kono, Kentaro Watanabe, Shunsuke Goto, Tatsuya Nishii, Atsushi Kono, Shinichi Nishi

Published in: Journal of Bone and Mineral Metabolism | Issue 3/2021

Login to get access

Abstract

Introduction

Very few studies have been performed to evaluate both the severity and site of aortic calcification (AC) in both end-stage kidney disease (ESKD) and diabetes mellitus (DM). The purpose of our study was to examine the utility of a newly developed three-dimensional (3D) visualization and quantification method compared with other methods to evaluate vascular calcification in ESKD patients with and without DM.

Materials and methods

Fifty patients with ESKD before initiating hemodialysis at our hospital were included in the present study. They were divided into the two groups, depending on the presence or absence of DM: Control group (n = 31) and DM group (n = 19). The volume and site of AC were evaluated via computed tomography (CT) scan using a 3D visualization and quantification method.

Results

Total calcification volume was significantly greater in the DM group than in the Control group. Calcification volume in the descending and abdominal aortas was greater in the DM group compared to the Control group. There were no significant differences in calcification volume in the aortic root, ascending aorta, and aortic arch. Calcification volume of the whole aorta, the descending aorta, and the abdominal aorta were each significantly correlated with age, diastolic blood pressure and pulse pressure.

Conclusion

This study using a 3D visualization and quantification method demonstrated that AC was more severe and occurred more frequently in the abdominal aorta in ESKD patients with DM compared to those without DM. This method would enable us to precisely evaluate the volume and distribution of AC.
Literature
1.
go back to reference Saran R, Robinson B, Abbott KC, Bragg-Gresham J, Chen X, Gipson D, Gu H, Hirth RA, Hutton D, Jin Y, Kapke A (2019) US renal data system 2019 annual data report. Am J Kidney Dis 75:A6CrossRef Saran R, Robinson B, Abbott KC, Bragg-Gresham J, Chen X, Gipson D, Gu H, Hirth RA, Hutton D, Jin Y, Kapke A (2019) US renal data system 2019 annual data report. Am J Kidney Dis 75:A6CrossRef
2.
go back to reference Ishigami J, Cowan LT, Demmer RT et al (2020) Incident hospitalization with major cardiovascular diseases and subsequent risk of ESKD: implications for cardiorenal syndrome. J Am Soc Nephrol 31:405–414CrossRef Ishigami J, Cowan LT, Demmer RT et al (2020) Incident hospitalization with major cardiovascular diseases and subsequent risk of ESKD: implications for cardiorenal syndrome. J Am Soc Nephrol 31:405–414CrossRef
3.
go back to reference Fujii H, Joki N (2017) Mineral metabolism and cardiovascular disease in CKD. Clin Exp Nephrol 21:S53CrossRef Fujii H, Joki N (2017) Mineral metabolism and cardiovascular disease in CKD. Clin Exp Nephrol 21:S53CrossRef
4.
go back to reference Goto S, Kitamura K, Kono K et al (2013) Association between AST-120 and abdominal aortic calcification in predialysis patients with chronic kidney disease. Clin Exp Nephrol 17:365–371CrossRef Goto S, Kitamura K, Kono K et al (2013) Association between AST-120 and abdominal aortic calcification in predialysis patients with chronic kidney disease. Clin Exp Nephrol 17:365–371CrossRef
5.
go back to reference Ishimura E, Okuno S, Kitatani K et al (2002) Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients–importance of glycaemic control. Diabetologia 45:1446–1448CrossRef Ishimura E, Okuno S, Kitatani K et al (2002) Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients–importance of glycaemic control. Diabetologia 45:1446–1448CrossRef
6.
go back to reference Detrano R et al (2008) Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 358:1336–1345CrossRef Detrano R et al (2008) Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 358:1336–1345CrossRef
7.
go back to reference Rennenberg RJ, Kessels AG, Schurgers LJ et al (2009) Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag 5:185–197CrossRef Rennenberg RJ, Kessels AG, Schurgers LJ et al (2009) Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag 5:185–197CrossRef
8.
go back to reference London GM, Guérin AP, Marchais SJ et al (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731–1740CrossRef London GM, Guérin AP, Marchais SJ et al (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18:1731–1740CrossRef
9.
go back to reference Moe S, Drüeke T, Cunningham J et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69:1945CrossRef Moe S, Drüeke T, Cunningham J et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69:1945CrossRef
10.
go back to reference Yahagi K et al (2017) Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus. Arterioscler Thromb Vasc Biol 37:191–204CrossRef Yahagi K et al (2017) Pathology of human coronary and carotid artery atherosclerosis and vascular calcification in diabetes mellitus. Arterioscler Thromb Vasc Biol 37:191–204CrossRef
11.
go back to reference Sarwar N, Gao P, Seshasai SR et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215–2222CrossRef Sarwar N, Gao P, Seshasai SR et al (2010) Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375:2215–2222CrossRef
12.
go back to reference Fukagawa M, Yokoyama K, Koiwa F et al (2013) CKD-MBD Guideline Working Group; Japanese Society for Dialysis Therapy. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial 17:247–288CrossRef Fukagawa M, Yokoyama K, Koiwa F et al (2013) CKD-MBD Guideline Working Group; Japanese Society for Dialysis Therapy. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial 17:247–288CrossRef
13.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO (2017) Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 7:1–59CrossRef Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO (2017) Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 7:1–59CrossRef
14.
go back to reference Fujii H, Kono K, Nakai K, Goto S, Nishii T, Kono A, Nishi S (2018) Effects of lanthanum carbonate on coronary artery calcification and cardiac abnormalities during initiating hemodialysis. Calcif Tissue Int 102:310–3208CrossRef Fujii H, Kono K, Nakai K, Goto S, Nishii T, Kono A, Nishi S (2018) Effects of lanthanum carbonate on coronary artery calcification and cardiac abnormalities during initiating hemodialysis. Calcif Tissue Int 102:310–3208CrossRef
15.
go back to reference Mori S, Takaya T, Kinugasa M et al (2015) Three-dimensional quantification and visualization of aortic calcification by multidetector-row computed tomography: a simple approach using a volume-rendering method. Atherosclerosis 239:622–628CrossRef Mori S, Takaya T, Kinugasa M et al (2015) Three-dimensional quantification and visualization of aortic calcification by multidetector-row computed tomography: a simple approach using a volume-rendering method. Atherosclerosis 239:622–628CrossRef
16.
go back to reference Hanada S, Ando R, Naito S, Kobayashi N, Wakabayashi M, Hata T, Sasaki S (2010) Assessment and significance of abdominal aortic calcification in chronic kidney disease. Nephrol Dial Transplant 25:1888–1895CrossRef Hanada S, Ando R, Naito S, Kobayashi N, Wakabayashi M, Hata T, Sasaki S (2010) Assessment and significance of abdominal aortic calcification in chronic kidney disease. Nephrol Dial Transplant 25:1888–1895CrossRef
17.
go back to reference Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832CrossRef Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832CrossRef
18.
go back to reference Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S1-130 Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S1-130
19.
go back to reference Goldsmith DA, Covic A, Fouque D et al (2010) Endorsement of the kidney disease improving global outcomes (KDIGO) chronic kidney disease-mineral and bone disorder (CKD-MBD) guidelines: a european renal best practice (ERBP) commentary statement. Nephrol Dial Transplant 25:3823–3831CrossRef Goldsmith DA, Covic A, Fouque D et al (2010) Endorsement of the kidney disease improving global outcomes (KDIGO) chronic kidney disease-mineral and bone disorder (CKD-MBD) guidelines: a european renal best practice (ERBP) commentary statement. Nephrol Dial Transplant 25:3823–3831CrossRef
20.
go back to reference Agatston AS, Janowitz WR, Hildner FJ et al (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832CrossRef Agatston AS, Janowitz WR, Hildner FJ et al (1990) Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 15:827–832CrossRef
21.
go back to reference Karohl C, Gascón LD, Raggi P (2011) Noninvasive imaging for assessment of calcification in chronic kidney disease. Nat Rev Nephrol 7:567–577CrossRef Karohl C, Gascón LD, Raggi P (2011) Noninvasive imaging for assessment of calcification in chronic kidney disease. Nat Rev Nephrol 7:567–577CrossRef
22.
go back to reference Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Goncalves M, Negrao AP (2004) A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 19:1480–1488CrossRef Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Goncalves M, Negrao AP (2004) A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 19:1480–1488CrossRef
23.
go back to reference Hanada S, Ando S, Naito S et al (2010) Assessment and significance of abdominal aortic calcification in chronic kidney disease. Nephrol Dial Transplant 25:1888–1895CrossRef Hanada S, Ando S, Naito S et al (2010) Assessment and significance of abdominal aortic calcification in chronic kidney disease. Nephrol Dial Transplant 25:1888–1895CrossRef
24.
go back to reference Vervloet M, Cozzolino M (2017) Vascular calcification in chronic kidney disease: different bricks in the wall? Kidney Int 91:808–817CrossRef Vervloet M, Cozzolino M (2017) Vascular calcification in chronic kidney disease: different bricks in the wall? Kidney Int 91:808–817CrossRef
25.
go back to reference Criqui MH, Denenberg JO, Ix JH et al (2014) Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA 311:271–278CrossRef Criqui MH, Denenberg JO, Ix JH et al (2014) Calcium density of coronary artery plaque and risk of incident cardiovascular events. JAMA 311:271–278CrossRef
26.
go back to reference Kono K, Fujii H, Nakai K et al (2012) Compositional plaque pattern of coronary culprit lesion and clinical characteristics in chronic kidney disease patients: a virtual histology-intravascular ultrasound (VH-IVUS) analysis. Kidney Int 82:344–351CrossRef Kono K, Fujii H, Nakai K et al (2012) Compositional plaque pattern of coronary culprit lesion and clinical characteristics in chronic kidney disease patients: a virtual histology-intravascular ultrasound (VH-IVUS) analysis. Kidney Int 82:344–351CrossRef
27.
go back to reference Manzoor S, Ahmed S, Ali A et al (2018) Progression of medial arterial calcification in CKD. Kidney Int Rep 3:1328–1335CrossRef Manzoor S, Ahmed S, Ali A et al (2018) Progression of medial arterial calcification in CKD. Kidney Int Rep 3:1328–1335CrossRef
28.
go back to reference Suzuki C, Nakamura S, Ishibashi-Ueda H, Yoshihara F, Kawano Y (2011) Evidence for severe atherosclerotic changes in chronic hemodialysis patients: comparative autopsy study against cardiovascular disease patients without chronic kidney disease. Ther Apher Dial 15:51–57CrossRef Suzuki C, Nakamura S, Ishibashi-Ueda H, Yoshihara F, Kawano Y (2011) Evidence for severe atherosclerotic changes in chronic hemodialysis patients: comparative autopsy study against cardiovascular disease patients without chronic kidney disease. Ther Apher Dial 15:51–57CrossRef
29.
go back to reference Itani Y, Watanabe S, Masuda Y (2004) Aortic calcification detected in a mass chest screening program using a mobile helical computed tomography unit. Circ J 68:538–541CrossRef Itani Y, Watanabe S, Masuda Y (2004) Aortic calcification detected in a mass chest screening program using a mobile helical computed tomography unit. Circ J 68:538–541CrossRef
30.
go back to reference Allison MA, Criqui MH, Wright CM (2004) Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol 24:331–336CrossRef Allison MA, Criqui MH, Wright CM (2004) Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol 24:331–336CrossRef
31.
go back to reference Fujii H, Nakai K, Goto S, Nishi S (2015) Clinical characteristics of the very elderly patients at hemodialysis initiation. Intern Med 54:579–583CrossRef Fujii H, Nakai K, Goto S, Nishi S (2015) Clinical characteristics of the very elderly patients at hemodialysis initiation. Intern Med 54:579–583CrossRef
Metadata
Title
Evaluation of aortic calcification using a three-dimensional volume-rendering method in patients with end-stage kidney disease
Authors
Hideki Fujii
Keiji Kono
Kentaro Watanabe
Shunsuke Goto
Tatsuya Nishii
Atsushi Kono
Shinichi Nishi
Publication date
01-05-2021
Publisher
Springer Singapore
Published in
Journal of Bone and Mineral Metabolism / Issue 3/2021
Print ISSN: 0914-8779
Electronic ISSN: 1435-5604
DOI
https://doi.org/10.1007/s00774-020-01172-4

Other articles of this Issue 3/2021

Journal of Bone and Mineral Metabolism 3/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine